| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945414 | The Annals of Thoracic Surgery | 2005 | 7 Pages |
Abstract
This study suggests that specific elastase inhibition with sivelestat could be a feasible therapeutic strategy for patients undergoing cardiopulmonary bypass to attenuate neutrophil-derived inflammatory response and organ injuries.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kanji MD, Yuji MD, PhD, Satoshi MD, PhD, Shoko BMT, Osamu MD, PhD, Yuzuru MD, PhD,